virological clearance (nasopharyngeal sample negative for SARS-CoV-2 virus) at the sample taken on days 8. Co-primary end-point: Hospital admission over the time-interval between day 0 (randomization) and day 15. clearance virologica (campione rinofaringeo negativo per il virus SARS-CoV-2) al campione prelevato nei giorni 7-9. (viene fatto anche un2° test al giorno 14-17)

virological clearance (nasopharyngeal sample negative for SARS-CoV-2 virus) at the sample taken on days 8. Co-primary end-point: Hospital admission over the time-interval between day 0 (randomization) and day 15. clearance virologica (campione rinofaringeo negativo per il virus SARS-CoV-2) al campione prelevato nei giorni 7-9. (viene fatto anche un2° test al giorno 14-17)